Spectrum of CD30 lymphoproliferative diseases from lymphomatoid papulosis to anaplastic large cell lymphoma

International Journal of Dermatology

Volumn 35, Issue 12, 1996, Pages 842-848

  Louvet, Sylvie ^b   Dompmartin, Anne ^a   Troussard, Xavier ^b   Galateau, Françoise ^b   Moreau, Anne ^b   Reman, Oumedalli ^b   Leporrier, Michel ^b   Leroy, Dominique ^b  

^a Service de Dermatologie   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; RETINOIC ACID;

ADULT; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; REVIEW;

EID: 0030455262     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb05048.x     Document Type: Review

References (61)

1. Schwab U, Stein H, Gerdes J, et al. Production of monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299:65-67.
2. Smith CA, Gruss HJ, Davis T, et al. CD 30-Antigen, a marker for Hodgkin's lymphoma is a receptor whose ligand defines an emerging family of cytokeratines with homology to TNF. Cell 1993; 73:1349-1360.
3. Schwarting R, Gerdes J, Durkop H, et al. Ber-H2 a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989; 74:1678-1689.
4. Falini B, Pileri S, Pizzolo G, et al. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor-necrosis-factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85:1-14.
5. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66:848-858.
6. Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988; i:292-293.
7. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84:1361-1392.
8. Banerjee SS, Heald J, Harris M. Twelve cases of Ki-1 positive anaplastic large-cell lymphoma of skin. J Clin Pathol 1991; 44:119-125.
9. Krishnan J, Tomaszewski MM, Kao GF. Primary cutaneous CD30-positive anaplastic large-cell lymphoma. Report of 27 cases. J Clin Pathol 1993; 20:193-202.
10. Kinney MC, Collins RD, Greer JP, et al. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 1993; 17:859-868.
11. Camisa C, Helm TN, Sexton C, et al. Ki-1 positive anaplastic large-cell lymphoma can mimic benign dermatoses. J Am Acad Dermatol 1993; 29:696-700.
12. Feller AC, Sterry W. Large cell anaplastic lymphoma of the skin. Br J Dermatol 1989; 121:593-602.
13. Kaudewitz P, Stein H, Dallenbach F, et al. Primary and secondary cutaneous Ki-1+(CD30)+ anaplastic large cell lymphomas. Morphologic, immunohistologic and clinical characteristics. Am J Pathol 1989; 135:359-367.
14. Penny RJ, Blaustein JC, Longtine JA, et al. Ki-1 positive large cell lymphomas, a heterogenous group of neoplasms. Morphologic, immunophenotypic, genotypic, and clinical features of 24 cases. Cancer 1991; 68:362-373.
15. Sterry W, Korte B, Schubert C. Pleomorphic T-cell lymphoma and large-cell anaplastic lymphoma of the skin. A morphological, immunophenotypical, and ultrastructural study of two typical cases. Am J Dermatopathol 1989; 11:112-123.
16. Wood GS, Bahler DW, Hoppe RT, et al. Transformation of mycosis fungoides: T-cell receptor β gene analysis demonstrates common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma. J Invest Dermatol 1993; 101:296-300.
17. Ralfkiaer E, Thomsen K, Agdal N, et al. The development of a Ki-1-positive large cell non-Hodgkin's lymphoma in pagetoid reticulosis. Acta Derm Venereol (Stockh) 1989; 69:206-211.
18. Chan JKC, Hui PK, Leung TW, et al. Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types. Histopathology 1989; 15:11-34.
19. Harrington DS, Braddock SW, Blocher KS, et al. Lymphomatoid papulosis and progression to T-cell lymphoma: an immunophenotypic and genotypic analysis. J Am Acad Dermatol 1989; 21:951-957.
20. Kaudewitz P, Herbst H, Anagnostopoulos I, et al. Lymphomatoid papulosis followed by large-cell lymphoma: immunophenotypical and genotypical analysis. Br J Dermatol 1991; 124:465-469.
21. Salhany KE, Cousar JB, Greer JP, et al. Transformation of cutaneous T-cell lymphoma to large-cell lymphoma. A clinicopathologic and immunologic study. Am J Pathol 1988; 132:265-277.
22. Tashiro K, Kikushi M, Takeshita M, et al. Clinicopathological study of Ki-1 positive lymphomas. Pathol Res Pract 1989; 185:461-467.
23. Motley RJ, Jasani B, Ford AM, et al. Regressing atypical histiocytosis, a regressing cutaneous phase of Ki-1 positive anaplastic large-cell lymphoma. Cancer 1992; 70:476-483.
24. Davis TH, Morton CC, Miller-Cassman R, et al. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 1992; 326:1115-1122.
25. Beljaards RC, Meijer CLLM, Scheffer E, et al. Prognostic significance of CD30 (Ki-1/Ber-H2): expression in primary cutaneous large-cell lymphoma of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 1989; 135:1169-1178.
26. Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large-cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study of 47 patients. Cancer 1993; 71:2097-2104.
27. Esteve E, Vaillant L, Machet MC, et al. Lymphome anaplasique CD30 positif cutané primitif révélé par une ulcération à type de pyoderma gangrenosum. Nouv Dermatol 1994; 13:30-31.
28. Bagot M, Wechsler J, Cosnes A, et al. Lymphomes à grandes cellules anaplasiques CD30 (Ki-1)+. Ann Dermatol Venereol 1989; 116:881-883.
29. Curco N, Servitje O, Sais G, et al. Primary cutaneous CD30-positive large-cell lymphoma: a case with fatal outcome. J Am Acad Dermatol 1994; 31:1068-1069.
30. Berti E, Gianotti R, Alessi E. Primary anaplastic large-cell lymphoma of the skin. Dermatologica 1989; 178: 225-227.
31. Sugimoto H, Nakayama F, Yamauchi T, et al. Ki-1+ cutaneous lymphoma. Gene rearrangement analysis of tumor cells in tissue and short-term culture of a patient. Arch Dermatol 1988; 124:405-408.
32. Lindholm JS, Barron DR, Williams ME, et al. Ki-1 positive cutaneous large-cell lymphoma of T cell type: report of indolent subtype. J Am Acad Dermatol 1989; 20:342-348.
33. Moulonguet I, Perrin P, Iskandar MJ, et al. Lymphome à grandes cellules Ki-1 avec xanthomisation des lésions sous chimiothérapie. Ann Dermatol Venereol 1989; 116:887-889.
34. Chow JM, Cheng AL, Su IJ, et al. 13-cis-Retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma. Cancer 1991; 67: 2490-2494.
35. Bitter MA, Franklin WA, Larson RA, et al. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 1990; 14:305-316.
36. Chott A, Kaserer K, Augustin I, et al. Ki-1-positive large-cell lymphoma. A clincopathologic study of 41 cases. Am J Surg Pathol 1990; 14:439-448.
37. Agnarson BA, Kadin ME. Ki-1 Positive large-cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988; 12:264-274.
38. Chan JCK, Buchanan R, Fletcher CDM. Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma. Am J Surg Pathol 1990; 14:983-988.
39. Greer JP, Kinney MC, Collins RD, et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 1991; 9:539-547.
40. Pileri S, Falini B, Delsol G, et al. Lymphohistiocytic T-cell lymphoma (anaplastic large-cell lymphoma CD30+/ Ki-1+ with a high content of reactive histiocytes). Histopathology 1990; 16:383-391.
41. Pileri S, Bocchia M, Baroni CD, et al. Anaplastic large-cell lymphoma (CD30+/Ki 1+): results of a prospective clinico-pathological study of 69 cases. Br J Haematol 1994; 86:513-523.
42. Kinney MC, Greer JP, Glick AD, et al. Anaplastic large-cell Ki-1 malignant lymphomas. Recognition, biological and clinical implications. Pathol Annu 1990; 26:1-24.
43. Kadin ME. The spectrum of Ki-1+ cutaneous lymphoma. Curr Prob Dermatol 1990; 19:132-143.
44. Rimokh R, Magaud JP, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large-cell lymphoma (Ki-1 lymphoma). Br J Haematol 1989; 71:31-36.
45. Fisher P, Nacheva E, Mason DY, et al. A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a (2;5) translocation and rearrangement of the T-cell receptor β-chain gene. Blood 1988; 72:234-240.
46. Kaneko Y, Frizzera G, Edamura S, et al. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 1989; 73:806-813.
47. Le Beau M, Bitter MA, Larson RA, et al. The t(2;5) (p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large-cell lymphoma. Leukemia 1989; 3:866-870.
48. Mason DY, Bastard C, Rimokh R, et al. CD30-positive large-cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35. Br J Haematol 1990; 74:161-168.
49. Shiota M, Fujimoto J, Takenaga M, et al. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 1994; 84:3648-3652.
50. Szur L, Levene GM, Harrison CV, et al. Primary cutaneous Hodgkin's disease. Lancet 1970; i:1016-1020.
51. Smith JL, Butler JJ. Skin involvement in Hodgkin's disease. Cancer 1980; 45:354-361.
52. Wood GS, Strickler JD, Deneau DG, et al. Lymphomatoid papulosis expresses immunophenotypes associated with T-cell lymphoma but not inflammation. J Am Acad Dermatol 1986; 15:444-458.
53. Hall PA, D'Ardenne AJ, Stansfeld AG. Paraffin section immunohistochemistry. II. Hodgkin's disease and large-cell anaplastic (Ki-1) lymphoma. Histopathology 1988; 13:161-169.
54. Pallensen G, Hamilton-Dutoit JJ. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am J Pathol 1988; 133:446-450.
55. Piris M, Brown DC, Gatter KC, et al. CD30 expression in non-Hodgkin's lymphoma. Histopathology 1990; 17:211-218.
56. MacCaulay WL. Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign-histologically malignant. Arch Dermatol 1968; 97:23-30.
57. Karp DL, Horn TD. Lymphomatoid papulosis. J Am Acad Dermatol 1994; 30:379-395.
58. Willemze R, Meyer CJLM, Van Vloten WA, et al. The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol 1982; 107:131-144.
59. Beljaards RC, Willemze R. The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol 1992; 126:596-602.
60. Pedailles S, Troussard X, Dompmartin A, et al. Cutaneous lesions in angiocentric T-cell lymphoma. Immunological, virological and genotypic studies. Eur J Dermatol 1993; 3:656-661.
61. Ralfkiaer E, Bosq J, Gatter KC, et al. Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates. Arch Dermatol Res 1987; 279:285-292.